@genesndiseases.bsky.socialWhy does #ColorectalCancer keep resisting #5Fluorouracil chemotherapy?
This study shows that arachidonic acid–driven lipophagy sustains resistant cells, suggesting a strategy to restore chemotherapy sensitivity. #DrugResistance
#OpenAccess #GenesAndDiseases: doi.org/10.1016/j.ge...
@monalisarout1701.bsky.socialFIT's Role Post-Adenoma Resection:
🧪 FIT reduced CRC risk by 44%, colonoscopy by 51%
📊 High CRC incidence when positive FIT lacks follow-up
🔍 Risk factors: alcohol, obesity, smoking
#ColorectalCancer #FIT #AdenomaResection https://tnyp.me/YCjv6Tx9/s
@everyonediesmedia.bsky.socialColorectal cancer now leads cancer deaths in adults under 50, rising sharply in 20s and 30s. Learn signs, screening & advocacy: 🎧 https://ow.ly/26Xa50YjKhH
#ColorectalCancer #CatherineOHara #ColonCancer #CancerScreening #EarlyDetection
@desertdragon42.bsky.socialFuck cancer! My brother collapsed this morning and is being admitted to the hospital.
Prayers, good thoughts, and healing vibes are all welcome.
Obviously, I can't travel because COVID.
@liversmdpi.bsky.social📢 New Review in #LiversMDPI
🧬 Vignone et al. review PSC-IBD epidemiology, pathophysiology, and management.
🩺 PSC-IBD is linked to increased colorectal cancer and cholangiocarcinoma risks.
📖 Read More: www.mdpi.com/2673-4389/6/...
@oopsmyopinion.bsky.social
@gastroagi.bsky.socialCould 5 years be enough after high-risk adenoma removal?
EPoS II found similar 5-year CRC incidence with 5-year vs 3-year surveillance, but the trial is still ongoing.
The real answer will come from the 10-year CRC outcomes.
@clinicaladvisor.bsky.social#ICYMI: Medicare will now allow NPs, PAs, and clinical nurse specialists to independently order covered, noninvasive #ColorectalCancer screening tests without physician approval. Read more here ⬇️ https://bit.ly/4rl5qqI
@gastrotoday.bsky.social
@suzidore1.bsky.social
@suzidore1.bsky.social
@suzidore1.bsky.social@suzidore1.bsky.social@suzidore1.bsky.social@suzidore1.bsky.social@suzidore1.bsky.social
@alliance-org.bsky.social🚨 Milestone reached: The ERASur colorectal cancer trial has surpassed one third patient accrual nationwide. The study is evaluating whether aggressive local therapy can improve survival in limited metastatic disease. #ClinicalTrials #ColorectalCancer https://bit.ly/ERASur26
@vcclibrary.bsky.socialColonoscopy Intervals and #ColorectalCancer Incidence after Adenoma Removal. www.nejm.org/doi/full/10....
@gastroagi.bsky.socialDo high-risk adenomas really need 3-year surveillance?
EPoS II asks whether 5 years could be enough—with long-term CRC outcomes ultimately deciding the answer.
@getpalliative.bsky.social#PalliativeCare Helps During - and After - Treatment of #colorectalcancer.
They will work with you to make changes to your diet, nutrition and fluids, which may help you stay out of the hospital.
More -> https://getpalliativecare.org/palliative-care-helps-you-live-with-colorectal-cancer/
